National
ETV Bharat / Gilead Sciences
Gilead Sciences gifts another 25,600 vials of Remdesivir to India
May 8, 2021
India receives 1.5 lakh Remdesivir from Gilead Sciences
May 5, 2021
India to import 4,50,000 vials of Remdesivir
Apr 30, 2021
'Remdesivir' reduces death risk in severe COVID-19 patients
Jul 11, 2020
Issue compulsory license to Indian manufacturers to produce generic Remdesivir: CPI(M) to govt
Jul 5, 2020
Gilead's $2,340 price for coronavirus drug draws criticism
Jun 29, 2020
US pharma giant seeks marketing authorisation from India for COVID-19 drug
May 30, 2020
Gilead's Remdesivir drug shows positive results in coronavirus patients who require extra oxygen
May 24, 2020
Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India
May 21, 2020
Gilead inks pact with 3 Indian drugmakers to produce, sell Remdesivir
May 13, 2020
Remdesivir is by far the best drug to freeze corona spread: US
Apr 30, 2020
Good News! Indian-American-led clinical trial of remdesivir in COVID-19 treatment shows positive results
Focus On Ground Issues To Counter Polarisation, Social Engineering In Bihar: CPI(ML) Leader
Rajouri: 21-Year-Old Woman Critically Injured After Allegedly Shooting Herself; Police Investigate
AIIMS-Equivalent Facilities To Faculties And Officials of Assam's Medical Colleges: Assam Cabinet Decision
Jharkhand Congress Discusses Strategies For Upcoming Budget Session Of Assembly
Maha Shivaratri 2025: Amit Shah, DK Shivakumar To Grace Isha Yoga Centre Celebrations In Coimbatore
IND vs PAK: Virat Kohli Smashes 51st ODI Century To Power India To Semi-Final With Six-Wicket Win
Congress To Hold AICC Session In Ahmedabad On April 8-9
Still Unclear Who Was Target Of Shinde's 'Don't Take Me Lightly' Remark: Ajit Pawar
Maharashtra Transport Minister Pratap Sarnaik Condemns Attack On ST Staff In Karnataka, Warns Of Stern Action
Five Tourists From West Bengal Killed, Five Injured In Road Accident In Gujarat
4 Min Read
Feb 15, 2025
1 Min Read
3 Min Read
Copyright © 2025 Ushodaya Enterprises Pvt. Ltd., All Rights Reserved.
